Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly operating margin; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
NeuroSense Therapeutics Ltd.
Market Cap
$7.19M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.19M
Operating Margin
-5025.53%
TTM Avg
-3024.64%
3Y Avg
-1688.76%
5Y Avg
-1108.68%
Market Cap
$7.15M
Operating Margin
-1942.20%
TTM Avg
-1316.46%
3Y Avg
-1768.86%
5Y Avg
-1413.19%
Market Cap
$7.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.31M
Operating Margin
-0.52%
TTM Avg
-80.25%
3Y Avg
-135.01%
5Y Avg
-301.00%
Market Cap
$7.07M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
Market Cap
$7.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-522.59%
5Y Avg
-762.76%
Market Cap
$7.46M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.88M
Operating Margin
0.00%
TTM Avg
-1223.20%
3Y Avg
-613.19%
5Y Avg
1724.04%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) | $7.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.19M | -5025.53% | -3024.64% | -1688.76% | -1108.68% |
| Longeveron Inc. (LGVN)vs › | $7.15M | -1942.20% | -1316.46% | -1768.86% | -1413.19% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -0.52% | -80.25% | -135.01% | -301.00% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | 0.00% | 0.00% | -19.45% | -19.45% |
| KALA BIO, Inc. (KALA)vs › | $7.04M | 0.00% | 0.00% | -522.59% | -762.76% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Exicure, Inc. (XCUR)vs › | $6.88M | 0.00% | -1223.20% | -613.19% | 1724.04% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | -4200.46% | -2747.44% | -7258.72% | -5806.97% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
